Mechanisms Limiting Distribution of the Threonine-Protein Kinase B-RaF(V600E) Inhibitor Dabrafenib to the Brain: Implications for the Treatment of Melanoma Brain Metastases

類似資料

• Factors Influencing the CNS Distribution of a Novel MEK-1/2 Inhibitor: Implications for Combination Therapy for Melanoma Brain Metastases
  著者:: Vaidhyanathan, Shruthi, 等
  出版事項: (2014)
• Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on the Brain Distribution of a Novel BRAF Inhibitor: Vemurafenib (PLX4032)
  著者:: Mittapalli, Rajendar K., 等
  出版事項: (2012)
• Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases
  著者:: Vaidhyanathan, Shruthi, 等
  出版事項: (2016)
• Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases
  著者:: Gampa, Gautham, 等
  出版事項: (2019)
• Drug Delivery to Melanoma Brain Metastases: Can Current Challenges Lead to New Opportunities?
  著者:: Gampa, Gautham, 等
  出版事項: (2017)